Schedule 13G ownership disclosure

Rhythm Pharmaceuticals Inc

COM · CUSIP: 76243J105

Event date: 2025-09-30

Filing-level shares
4,262,859.00
Percent of class
6.42%
  • PRIMECAP MANAGEMENT CO/CA/

    Shares: 4,262,859.00 · Class: 6.42%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-005989
Form type
SCHEDULE 13G/A
Filer
PRIMECAP MANAGEMENT CO/CA/
CIK
CIK 763212
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub